STOCKWATCH
·
 Medicinal Chemicals and Botanical Products
BuybackMay 6, 2026, 08:32 AM

Upexi Repurchases 2.89M Shares; $47.2M Remains on Buyback Program

AI Summary

Upexi, Inc. provided an update on its $50 million authorized share repurchase program. As of May 5, 2026, the company has repurchased a total of 2,894,287 shares of common stock, with $47,226,036 remaining on the program. Management intends to continue using the program to maximize shareholder value. Upexi is also a digital asset treasury company focused on acquiring Solana (SOL) and currently holds approximately 2.4 million SOL.

Key Highlights

  • Upexi repurchased 2,894,287 shares as of May 5, 2026.
  • $47,226,036 remains on the $50 million share repurchase program.
  • The company has spent $2,773,964 on share repurchases to date.
  • In February 2026, 1,637,500 shares were bought for $1,246,450.70.
  • In March 2026, 840,561 shares were bought for $728,230.80.
  • Upexi currently holds approximately 2.4 million Solana (SOL).
UPXI
Medicinal Chemicals and Botanical Products
UPEXI, INC.

Price Impact